Clinical trial
AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomas
NCT03205176
Study timeline
Study start (actual)2017-06-30Date precision: day
Registry last updated2021-05-06
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Malignant Solid Tumorsunresolved
Lymphomaunresolved
Ovarian Cancerunresolved
Breast Cancerunresolved
Pancreatic Cancerunresolved
Prostate Cancerunresolved
Interventions
AZD5153DRUG
OlaparibDRUG · verified · RxNorm: olaparib
Sponsors & collaborators
AstraZenecalead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03205176 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.